Introduction

Dorn Spinal Therapy

Spine Healing Therapy

Get Instant Access

The spondyloarthritides (SpA) comprise ankylosing spondylitis (AS), reactive arthritis (ReA), arthritis/spondylitis with inflammatory bowel disease and arthritis/spon-dylitis with psoriasis. All these diseases are associated with HLA-B27, although to a different degree (Tab. 1). Further links between these diseases is the possible occurrence of similar clinical symptoms such as inflammatory back pain (predominant in the morning/at night and improvement with exercise) reflecting sacroiliitis/spondyli-tis, a similar pattern of peripheral joint involvement with an asymmetrical arthritis predominantly of the lower limbs, and in about 20% of patients the manifestations of enthesitis and uveitis. Furthermore, a substantial proportion of the HLA-B27-positive patients with reactive arthritis, arthritis/spondylitis associated with inflammatory bowel disease or psoriasis do develop ankylosing spondylitis (see below). AS is regarded as the SpA with the most severe outcome; it normally starts in the second decade of life. The male to female ratio has more recently been estimated to be around 2:1 [1]. The disease normally starts with inflammation in the sacroiliac joint but can affect the whole spine, with progressive spinal ankylosis as a potential outcome in a subgroup of patients. The association of HLA-B27 with AS/SpA is the highest known MHC Class I association for human diseases and the most relevant single factor for the pathogenesis of SpA. However, other less well defined genetical factors also contribute to the overall genetic risk.

Was this article helpful?

0 0

Post a comment